
3 Health Care Stocks Driving The Sector Higher
All three major indices are trading down today with the
Dow Jones Industrial Average
(
^DJI
) trading down 29 points (-0.2%) at 17,702 as of Tuesday, Nov. 10, 2015, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,315 issues advancing vs. 1,646 declining with 122 unchanged.
The Health Care sector currently sits down 0.8% versus the S&P 500, which is down 0.3%. Top gainers within the sector include
(
), up 1.2%,
(
), up 1.2%,
(
), up 0.9%,
(
), up 0.8% and
(
), up 0.7%. On the negative front, top decliners within the sector include
(
), down 11.8%,
(
), down 11.0%,
Valeant Pharmaceuticals International
(
), down 7.1%,
(
), down 4.1% and
(
), down 3.7%.
TheStreet would like to highlight 3 stocks pushing the sector higher today:
3.
(
) is one of the companies pushing the Health Care sector higher today. As of noon trading, Hologic is up $0.69 (1.7%) to $40.33 on light volume. Thus far, 654,013 shares of Hologic exchanged hands as compared to its average daily volume of 2.9 million shares. The stock has ranged in price between $39.47-$40.34 after having opened the day at $39.47 as compared to the previous trading day's close of $39.64.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Hologic has a market cap of $11.3 billion and is part of the health services industry. Shares are up 48.2% year-to-date as of the close of trading on Monday. Currently there are 9 analysts who rate Hologic a buy, no analysts rate it a sell, and 9 rate it a hold.
TheStreet Ratings rates
Hologic
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and unimpressive growth in net income. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
2. As of noon trading,
(
) is up $0.74 (0.6%) to $134.51 on light volume. Thus far, 295,947 shares of Anthem exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $133.54-$135.67 after having opened the day at $133.77 as compared to the previous trading day's close of $133.77.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. Anthem has a market cap of $35.0 billion and is part of the health services industry. Shares are up 6.5% year-to-date as of the close of trading on Monday. Currently there are 9 analysts who rate Anthem a buy, no analysts rate it a sell, and 6 rate it a hold.
TheStreet Ratings rates
Anthem
as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
1. As of noon trading,
(
) is up $1.17 (1.0%) to $115.43 on light volume. Thus far, 879,196 shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $114.03-$115.55 after having opened the day at $114.37 as compared to the previous trading day's close of $114.26.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $109.4 billion and is part of the health services industry. Shares are up 13.0% year-to-date as of the close of trading on Monday. Currently there are 17 analysts who rate UnitedHealth Group a buy, no analysts rate it a sell, and 1 rates it a hold.
TheStreet Ratings rates
UnitedHealth Group
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full
UnitedHealth Group Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider
Health Care Select Sector SPDR
(
) while those bearish on the health care sector could consider
ProShares Ultra Short Health Care
(
).








